Literature DB >> 16205947

Cancer-associated loss of TARSH gene expression in human primary lung cancer.

Kunihiko Terauchi1, Junichi Shimada, Natsuko Uekawa, Takeshi Yaoi, Mitsuo Maruyama, Shinji Fushiki.   

Abstract

PURPOSE: We have previously identified mouse Tarsh as one of the cellular senescence-related genes and showed the loss of expression of TARSH mRNA in four human lung cancer cell lines. TARSH is a presumptive signal transduction molecule interacting with NESH, which is implicated to have some roles in lung cancer metastasis.
METHODS: The amplification of complete ORF-encoding TARSH cDNA was done with reverse transcription-PCR. Northern blotting was carried out using TARSH cDNA probes. To clarify the relationship between TARSH and lung cancer, we quantified TARSH mRNA expression in 15 human lung cancer cell lines and 32 primary non-small cell lung cancers.
RESULTS: We first determined the complete ORF-encoding cDNA sequence which is expressed in the human lung. On the Northern hybridization analysis, TARSH was strongly expressed in the human lung. The expression of TARSH mRNA is remarkably downregulated in all the lung cancer cell lines examined. Furthermore, TARSH expression was significantly low in all of the tumor specimens when compared to the expression in corresponding non-neoplastic lung tissue specimens.
CONCLUSION: The cancer-associated transcriptional inactivation of TARSH suggests that TARSH could be used as a biomarker for lung cancer development as well as a molecular adjunct for lung carcinogenesis in human.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16205947     DOI: 10.1007/s00432-005-0032-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

1.  Cloning and sequencing of a novel human gene that encodes a putative target protein of Nesh-SH3.

Authors:  S Matsuda; C Iriyama; S Yokozaki; Y Ichigotani; N Shirafuji; K Yamaki; T Hayakawa; M Hamaguchi
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

2.  Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells.

Authors:  Yasukatu Ichigotani; Shouichi Yokozaki; Yoshihide Fukuda; Michinari Hamaguchi; Satoru Matsuda
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

3.  A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.

Authors:  Janete M Cerutti; Rosana Delcelo; Marcelo João Amadei; Claudia Nakabashi; Rui M B Maciel; Bercedis Peterson; Jennifer Shoemaker; Gregory J Riggins
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

4.  Expression of TARSH gene in MEFs senescence and its potential implication in human lung cancer.

Authors:  Natsuko Uekawa; Kunihiko Terauchi; Akihiko Nishikimi; Jun-ichi Shimada; Mitsuo Maruyama
Journal:  Biochem Biophys Res Commun       Date:  2005-04-15       Impact factor: 3.575

5.  Resection rates and postoperative mortality in 7,899 patients with lung cancer.

Authors:  R A Damhuis; P R Schütte
Journal:  Eur Respir J       Date:  1996-01       Impact factor: 16.671

Review 6.  How many tumor suppressor genes are involved in human lung carcinogenesis?

Authors:  T Kohno; J Yokota
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

Review 7.  Pathology of small-cell lung cancer.

Authors:  K Junker; T Wiethege; K M Müller
Journal:  J Cancer Res Clin Oncol       Date:  2000-07       Impact factor: 4.553

8.  p53: a frequent target for genetic abnormalities in lung cancer.

Authors:  T Takahashi; M M Nau; I Chiba; M J Birrer; R K Rosenberg; M Vinocour; M Levitt; H Pass; A F Gazdar; J D Minna
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

9.  Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.

Authors:  Rosa González-Quevedo; Cristina García-Aranda; Alberto Morán; Carmen De Juan; Andrés Sánchez-Pernaute; Antonio Torres; Eduardo Díaz-Rubio; Jose-Luis Balibrea; Manuel Benito; Pilar Iniesta
Journal:  Int J Oncol       Date:  2004-02       Impact factor: 5.650

10.  Survival analysis of untreated patients with non-small-cell lung cancer.

Authors:  E Vrdoljak; K Mise; D Sapunar; A Rozga; M Marusić
Journal:  Chest       Date:  1994-12       Impact factor: 9.410

View more
  8 in total

1.  Variable Susceptibility to Cigarette Smoke-Induced Emphysema in 34 Inbred Strains of Mice Implicates Abi3bp in Emphysema Susceptibility.

Authors:  Josiah E Radder; Alyssa D Gregory; Adriana S Leme; Michael H Cho; Yanxia Chu; Neil J Kelly; Per Bakke; Amund Gulsvik; Augusto A Litonjua; David Sparrow; Terri H Beaty; James D Crapo; Edwin K Silverman; Yingze Zhang; Annerose Berndt; Steven D Shapiro
Journal:  Am J Respir Cell Mol Biol       Date:  2017-09       Impact factor: 6.914

2.  Abi3bp is a multifunctional autocrine/paracrine factor that regulates mesenchymal stem cell biology.

Authors:  Conrad P Hodgkinson; Vinogran Naidoo; Karl G Patti; Jose A Gomez; Jeffrey Schmeckpeper; Zhiping Zhang; Bryce Davis; Richard E Pratt; Maria Mirotsou; Victor J Dzau
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

3.  Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion.

Authors:  Flavia R M Latini; Jefferson P Hemerly; Gisele Oler; Gregory J Riggins; Janete M Cerutti
Journal:  Endocr Relat Cancer       Date:  2008-06-17       Impact factor: 5.678

4.  ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence.

Authors:  Flavia R M Latini; Jefferson P Hemerly; Beatriz C G Freitas; Gisele Oler; Gregory J Riggins; Janete M Cerutti
Journal:  BMC Cancer       Date:  2011-01-11       Impact factor: 4.430

5.  Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.

Authors:  Nan Lin; Zhicheng Yao; Mingxing Xu; Jingyao Chen; Yi Lu; Lin Yuan; Shuqin Zhou; Xiaoguang Zou; Ruiyun Xu
Journal:  J Exp Clin Cancer Res       Date:  2019-06-07

6.  Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells.

Authors:  Yin Xiong; Sichuan Xi; Sudheer Kumar Gara; Jigui Shan; James Gao; Mary Zhang; Vivek Shukla; Ruihong Wang; Chuong D Hoang; Haobin Chen; David S Schrump
Journal:  JTO Clin Res Rep       Date:  2021-05-08

7.  Exome sequencing characterizes the somatic mutation spectrum of early serrated lesions in a patient with serrated polyposis syndrome (SPS).

Authors:  Sukanya Horpaopan; Jutta Kirfel; Sophia Peters; Michael Kloth; Robert Hüneburg; Janine Altmüller; Dmitriy Drichel; Margarete Odenthal; Glen Kristiansen; Christian Strassburg; Jacob Nattermann; Per Hoffmann; Peter Nürnberg; Reinhard Büttner; Holger Thiele; Philip Kahl; Isabel Spier; Stefan Aretz
Journal:  Hered Cancer Clin Pract       Date:  2017-11-29       Impact factor: 2.857

8.  The Depletion of ABI3BP by MicroRNA-183 Promotes the Development of Esophageal Carcinoma.

Authors:  Hongfei Cai; Yang Li; Da Qin; Rui Wang; Ze Tang; Tianyu Lu; Youbin Cui
Journal:  Mediators Inflamm       Date:  2020-07-26       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.